Results 251 to 260 of about 172,419 (302)

Cancer-control outcomes of patients with metastatic hormone-sensitive prostate cancer and ≥ 10 bone metastases receiving apalutamide: a real-world cohort. [PDF]

BMC Cancer
Wenzel M, Filzmayer M, Siech C, Le QC, Lauer B, Theissen L, Hoeh B, Heinzer H, Graefen M, Steuber T, Kriegmair M, Chun FK, Mandel P.   +12 more
europepmc   +1 more source

Timely Integration of specialist palliative care into oncology care for patients receiving radiotherapy for bone metastases: A study procotol for the TIPZO-RT Randomized Controlled Trial. [PDF]

PLoS One
van Oss A, van der Velden JM, Verkooijen HM, van Jaarsveld R, Hesselmann GM, Kuip EJM, Westhoff PG, Raijmakers NJH, van der Linden YM, Gal R.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Markers of bone turnover in bone metastases

Cancer, 2000
Bone metastases are a frequent complication of cancer disease. The evaluation of metastatic bone disease is crucial for the primary cancer staging because it will influence the therapeutic decision. The diagnosis of bone metastases usually relies on skeletal X-ray and bone scintigraphy.
P D Delmas
exaly   +3 more sources

Radiotherapy of bone metastases

Cancer/Radiothérapie, 2022
We present the update of the recommendations of the French society of oncological radiotherapy on bone metastases. This is a common treatment in the management of patients with cancer. It is a relatively simple treatment with proven efficacy in reducing pain or managing spinal cord compression. More complex treatments by stereotaxis can be proposed for
S, Thureau, S, Supiot, E, Jouglar, M, Rogé, L, Lebret, A, Hadj Henni, G, Beldjoudi, J-L, Lagrange, J-C, Faivre   +8 more
openaire   +2 more sources

Radiopharmaceuticals for Bone Metastases

Seminars in Radiation Oncology, 2021
As a single organ distributed diffusely throughout the body, bones represent both a unique challenge and unique opportunity for the treatment of symptomatic metastatic disease. While the multifocality of bone metastases often prevents effective complete treatment with focal radiotherapy, the similar pathophysiology of these diffuse sites of disease ...
Andrew W, Smith, Benjamin A, Greenberger, Robert B, Den, Richard G, Stock   +3 more
openaire   +2 more sources

Epidemiology of bone metastases

Bone, 2022
This study evaluated the incidence of de novo bone metastasis across all primary cancer sites and their impact on survival by primary cancer site, age, race, and sex.Our objectives were (I) characterize the epidemiology of de novo bone metastasis with respect to patient demographics, (II) characterize the incidence by primary site, age, and sex (2010 ...
Ryan, Casey, Stoltzfus, Kelsey C., Horn, Samantha, Chen, Hanbo, Louie, Alexander V., Lehrer, Eric J., Trifiletti, Daniel M., Fox, Edward J., Abraham, John A., Zaorsky, Nicholas G.   +9 more
openaire   +3 more sources

Radiotherapy for Bone Metastases

Clinical Oncology, 2001
Radiotherapy for Bone Metastases P. J. Hoskin, J. R. Yarnold, D. R. Roos and S. Bentzen, on behalf of the participants of the Second Workshop on Palliative Radiotherapy and Symptom Control, London, 2000 Mount Vernon Hospital, Northwood, UK, Royal Marsden Hospital, Sutton, UK, Royal Adelaide Hospital, Adelaide, Australia and Gray Laboratory Research ...
P J, Hoskin, J R, Yarnold, D R, Roos, S, Bentzen   +3 more
openaire   +2 more sources

Bone Metastases

The Cancer Journal
Abstract Bone metastases occur frequently in common malignancies such as breast and prostate cancer. They are responsible for considerable morbidity and skeletal-related events. Fortunately, there are now several systemic, focal, and targeted therapies that can improve quality and length of life, including radionuclide therapies.
Gary J R, Cook, Matthew P, Thorpe
openaire   +3 more sources

Ablation of Bone Metastases

Surgical Oncology Clinics of North America, 2011
Metastatic disease is the most common neoplasm involving the skeletal system and can result in significant pain and morbidity. Although narcotic medications and external beam radiation therapy remain the standard of care, several image-guided ablation techniques have evolved to play a role in the management of painful bone metastases.
Javier, Nazario, Alda L, Tam
openaire   +2 more sources